Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
3.650
+0.020 (0.55%)
At close: Jul 30, 2026, 4:00 PM EDT
3.556
-0.094 (-2.59%)
After-hours: Jul 30, 2026, 7:34 PM EDT

[Name] Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2571781116
Market Cap Growth
32.23%947.72%-14.33%-26.39%-33.33%67.05%
Enterprise Value
10.7358.756.543.46-1.864.72
Last Close Price
3.6512.8128.7543.75120.00393.75
Forward PE
-2.562.562.562.562.56
PS Ratio
4.8513.631.161.6148.00-
PB Ratio
2.0917.78-0.76---
P/TBV Ratio
2.0812.11----
EV/Sales Ratio
2.0711.271.120.70-8.32-
EV/EBITDA Ratio
----0.10-
EV/EBIT Ratio
----0.09-
EV/FCF Ratio
----0.14-
Debt / Equity Ratio
0.060.19-0.37---
Net Debt / Equity Ratio
-1.20-3.080.03---
Net Debt / EBITDA Ratio
0.780.830.020.350.660.97
Net Debt / FCF Ratio
0.660.590.020.350.970.88
Asset Turnover
0.290.450.650.280.010
Quick Ratio
2.071.090.270.801.533.13
Current Ratio
2.271.230.340.921.843.36
Return on Equity (ROE)
-137.51%903.94%290.04%---
Return on Assets (ROA)
-104.20%-133.27%-163.09%-75.57%-85.99%-72.91%
Return on Invested Capital (ROIC)
-825.58%-458.64%-283.69%-282.88%-509.09%-185.96%
Return on Capital Employed (ROCE)
-236.43%623.52%355.94%-210.18%-140.17%-126.30%
Buyback Yield / Dilution
-1157.41%-910.35%-145.18%-79.45%-117.18%-173.03%
Total Shareholder Return
-1157.41%-910.35%-145.18%-79.45%-117.18%-173.03%
SEC Filings: 10-K · 10-Q